Verve Therapeutics
VERV
#7018
Rank
HK$3.19 B
Marketcap
HK$37.73
Share price
5.43%
Change (1 day)
-60.06%
Change (1 year)

EPS for Verve Therapeutics (VERV)

EPS in 2023 (TTM): -HK$24.85

According to Verve Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$24.66. In 2022 the company made an earnings per share (EPS) of -HK$22.72 a decrease over its 2021 EPS that were of -HK$19.66.

EPS history for Verve Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$24.859.38%
2022-HK$22.7215.54%
2021-HK$19.6661.32%
2020-HK$12.19